Amesite Inc. (AMST)
Business Summary
Amesite Inc. is a technology company focused on building and commercializing AI-powered solutions for the enterprise and for professionals, with particular emphasis on the post-acute healthcare market. The company operates through two product lines: NurseMagic™ and LynkMagic™. NurseMagic™ solutions include a B2B enterprise application and a B2C solution for individual healthcare professionals, while LynkMagic™ provides enterprise AI solutions for healthcare and related organizations. The healthcare software market is comprised of several distinct segments, including Electronic Medical Record (EMR) or Electronic Health Record (EHR) firms, mid-market and specialized vendors, AI-first entrants, and niche clinical tools vendors. NurseMagic™ has been designed to be at the intersection of these segments, combining rapid deployment, practitioner-driven design, and robust compliance to meet evolving needs in post-acute care.
The healthcare software industry is intensely competitive, with established platforms, agile mid-market firms, and numerous AI-first entrants, many of whom have more resources and larger installed bases. Amesite faces substantial competition from existing players who have already overcome hurdles in the space. The company believes that its adoption rates and enterprise wins suggest its focus on real workflow impact, security, and regulatory alignment is resonating. Amesite's continued success will depend on maintaining speed, responsiveness, and disciplined execution in an industry defined by complexity and rapid change.
Amesite generates revenue through a hosted platform of tightly integrated technology and services, with pricing for customer contracts based on a fixed monthly fee. Revenue is recognized ratably over the service period, generally one month. The company derives revenue from B2B license fee revenues related to the NurseMagic™ app and from B2C subscriptions for individual healthcare professionals. The company offers a free version of NurseMagic™ for individual nurses and caregivers to lower barriers to adoption, while B2B sales target healthcare enterprises operating in post-acute settings, spanning home health, skilled nursing, hospice, assisted and senior living centers.
NurseMagic™ is a mobile healthcare app that streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations. It is available in multiple subscription tiers, from individual nurses and small care teams to large healthcare enterprises. Individual users and team leads can initiate a 7-day free trial via a simple, self-purchase process. For enterprises, the company offers both standard and customized models, allowing for rapid and broad implementation. In fiscal 2026, the company launched a census-based Enterprise tier with EMR compatibility, automated interdisciplinary team reporting, and configurable documentation, and introduced the AI-native NurseMagic™ EMR capability.
LynkMagic™ provides enterprise AI solutions for healthcare and related organizations, including specialized operational and analytics use cases. The Amesite Engage platform, the company's AI-powered application which provides solutions for professional, educational and individual needs, remains a performant solution for its user base, though the company is not currently dedicating resources to its growth. The company's technology platform is purpose-built to rapidly deliver high-impact, compliant solutions across healthcare and corporate learning, powering NurseMagic™, LynkMagic™ and Amesite Engage from a coordinated infrastructure built for security, flexibility, and speed.
In fiscal 2026, Amesite secured its largest enterprise deployment to date, serving an approximately 2,700-patient census. The company launched a census-based Enterprise tier with EMR compatibility, automated interdisciplinary team reporting, and configurable documentation, and introduced the AI-native NurseMagic™ EMR capability. On January 8, 2025, the company closed on a public offering of its common stock and received approximately $3.08 million of cash proceeds, net of underwriting discounts, commissions and other offering costs. On April 28, 2026, the company closed on a registered direct offering of 696,866 shares of common stock at a purchase price of $1.435 per share, a concurrent private placement of pre-funded warrants to purchase 696,866 shares of common stock and common warrants to purchase an aggregate of 2,787,464 shares of common stock, and an insider-led private placement of 418,118 shares of common stock and common warrants to purchase an aggregate of 836,236 shares of common stock. The aggregate gross proceeds from the registered direct offering and private placement were approximately $2.0 million, and the aggregate gross proceeds from the insider-led private placement were approximately $600,000, in each case prior to deducting placement agent fees and other offering expenses.
Amesite generated revenues of $364,777 for the year ended June 30, 2026 as compared to $110,459 for the year ended June 30, 2025. The company incurred a net loss of $3,095,838 for the twelve months ended June 30, 2026, compared to a net loss of $3,617,086 for the year ended June 30, 2025. The loss was $521,248 lower during the year ended June 30, 2026 compared to 2025 primarily due to significant savings in general and administrative, technology and content development, and sales and marketing expenses. As of June 30, 2026, the company's cash balance totaled $2,398,809, inclusive of $100,000 restricted cash.
Business Outlook & Financial Sufficiency
Management believes that it may not have sufficient cash and cash equivalents to maintain the Company's planned operations for the next twelve months following the issuance of these financial statements. Management plans include generating cash by completing financing transactions, which may include offerings of common stock. However, these plans are subject to market conditions, and are not within the Company's control, and therefore, cannot be deemed probable. There is no assurance that the Company will be successful in implementing their plans.
Amesite's primary growth vector is the expansion of NurseMagic™ across the post-acute healthcare market, including home health, skilled nursing, hospice, assisted and senior living centers. The company's B2C solution offers a free version, enabling decision-makers to test the app and quickly validate impact and reduce hesitancy. The company emphasizes NurseMagic™'s potential to save time, support regulatory compliance, enhance documentation accuracy, and drive measurable improvements in staff efficiency and retention. The company aims to be fully deployable to every type of employee in an enterprise, requiring no external system integration, and is administered entirely within the app.
Another growth vector is the introduction and expansion of LynkMagic™ enterprise solutions for healthcare and related organizations, including specialized operational and analytics use cases. The company continues to pursue enterprise opportunities in post-acute care and related healthcare segments. The company's go-to-market strategies for NurseMagic™ and LynkMagic™ are distinctly structured for B2C and B2B audiences, leveraging growing insights from both segments to build market share, drive recurring revenue, and establish the brand as a trusted, high-value solution for all individual nurses, and for businesses in post-acute care.
The company's margin and cost outlook is focused on fiscal discipline, launching and scaling innovative products while managing costs and prioritizing efficient resource allocation. General and administrative expenses for the year ended June 30, 2026 were relatively consistent at $2,510,264 as compared to $2,477,888 for the year ended June 30, 2025. Technology and content development expenses for the year ended June 30, 2026 were $613,578 as compared to $691,154 for the year ended June 30, 2025. Sales and marketing expenses for the year ended June 30, 2026 were $384,041 as compared to $545,030 for the year ended June 30, 2025.
The company operates remotely with no lease obligations and believes that its existing remote environment is adequate for its current needs. As of June 30, 2026, the company has 5 full-time employees and 1 consultant. The company intends to engage consultants in general administration on an as-needed basis and also intends to engage experts in operations, finance and general business to advise in various capacities. The company's R&D culture is focused on agility, regularly launching new features and capabilities, often averaging in excess of five per week.
During the years ended June 30, 2026 and 2025, the company had capital asset additions of $225,098 and $378,300, respectively, which were all comprised of capitalized technology and content development. The company will continue to capitalize significant software development costs, comprised primarily of internal payroll, payroll related and contractor costs, as it builds out and completes its technology platforms. The company does not anticipate declaring or paying any cash dividends for the foreseeable future.
The company faces significant risks related to its ability to continue as a going concern, as management believes it may not have sufficient cash and cash equivalents to maintain planned operations for the next twelve months following the issuance of the financial statements. The company has a history of net losses and negative cash flows from operating activities since inception and expects to continue to incur net losses and use cash in its operations in the foreseeable future. The company's future performance depends on continued growth in the post-acute care market, successful marketing and sales execution, and the overall pace of adoption of AI-powered solutions in healthcare.
The company faces substantial competition from existing players in the healthcare software market, including established EMR/EHR firms, mid-market and specialized vendors, AI-first entrants, and niche clinical tools vendors. Market acceptance could be impeded by factors including organizational inertia, integration challenges, the emergence of competing technologies, or negative perceptions of AI in clinical environments. The company also faces compliance and regulatory risks related to HIPAA, the HITECH Act, CMS rules, and emerging AI-focused regulations, which could expose it to significant penalties, legal action, or restrictions on its business.
Management Sentiments & Priorities
Management's message emphasizes a strategic pivot toward the healthcare market, with a focus on delivering AI tools to markets hungry for increased capability that immediately impacts both performance and bottom line. The company has undertaken a strategic pivot aimed at growing its customer base while reducing risk and losses, resulting in a larger client base and a dramatic reduction in cash burn. Management believes that the company has consistently endeavored to provide strong fiscal discipline, launching and scaling innovative products while managing costs and prioritizing efficient resource allocation. The company's mission is to empower people with AI tools, and its values are summarized in its 'beats' guideposts for culture, including judgment beats rules, measurement beats conjecture, humility beats arrogance, honesty beats politeness, growth beats comfort, transparency beats manipulation, and passion beats indifference. Management acknowledges significant risks remain in the space as the company navigates customer, regulatory and user requirements, while continuing to strive to offer innovative solutions.
Financial Details
Net revenue for the year ended June 30, 2026 was $364,777, compared to $110,459 for the year ended June 30, 2025. Net loss for the year ended June 30, 2026 was $3,095,838, compared to a net loss of $3,617,086 for the year ended June 30, 2025. Basic and diluted loss per share was $(0.63) for the year ended June 30, 2026, compared to $(1.03) for the year ended June 30, 2025. Loss from operations was $3,143,106 for the year ended June 30, 2026, compared to $3,603,613 for the year ended June 30, 2025. Interest income totaled $47,268 for the year ended June 30, 2026, compared to $77,396 for the year ended June 30, 2025. The company recognized impairment losses of $0 and $90,869 for the fiscal years ended June 30, 2026 and 2025, respectively, related to capitalized software. As of June 30, 2026, cash and cash equivalents totaled $2,298,809, and total cash, cash equivalents, and restricted cash was $2,398,809. Net cash used in operating activities was $2,146,717 for the year ended June 30, 2026, compared to $2,455,248 for the year ended June 30, 2025. Net cash provided by financing activities was $2,342,927 for the year ended June 30, 2026, compared to $3,095,950 for the year ended June 30, 2025. Revenue from B2B customers was $297,673, representing 82% of total revenue for the year ended June 30, 2026, compared to $83,458, representing 76% of total revenue for the year ended June 30, 2025. Revenue from B2C customers was $67,104, representing 18% of total revenue for the year ended June 30, 2026, compared to $27,001, representing 24% of total revenue for the year ended June 30, 2025.
Risk Factors
The company has concluded that there is substantial doubt about its ability to continue as a going concern, as management believes it may not have sufficient cash and cash equivalents to maintain planned operations for the next twelve months following the issuance of the financial statements. The company has a history of net losses, with net losses of approximately $3,096,000 and $3,617,000 for the years ended June 30, 2026 and 2025, respectively. The company's future performance depends on continued growth in the post-acute care market and successful adoption of its AI-powered solutions, but the healthcare software industry is intensely competitive, with established platforms, agile mid-market firms, and numerous AI-first entrants, many of whom have more resources and larger installed bases. The company faces significant compliance and regulatory risks, as its NurseMagic™ solution is designed for use across post-acute healthcare settings subject to extensive federal and state regulations, including HIPAA, the HITECH Act, CMS rules, and emerging AI-focused regulations, and any failure to maintain compliance could expose the company to significant penalties, legal action, or restrictions on its business. The company also faces cybersecurity and data protection risks inherent in managing health-related and personal information, and any breach, unauthorized access, or misuse could have severe financial, reputational, and legal consequences.
References
- [1] Item 1, Business — Overview
- [2] Item 1, Business — Competition
- [3] Item 1, Business — Overview
- [4] Item 7, MD&A — Results of Operations
- [5] Item 7, MD&A — Results of Operations
- [6] Item 7, MD&A — Financial Position, Liquidity, and Capital Resources
- [7] Item 7, MD&A — Financial Position, Liquidity, and Capital Resources
- [8] Item 7, MD&A — Financial Position, Liquidity, and Capital Resources
- [9] Item 7, MD&A — Financial Position, Liquidity, and Capital Resources
- [10] Item 7, MD&A — Financial Position, Liquidity, and Capital Resources
- [11] Item 7, MD&A — Results of Operations
- [12] Item 7, MD&A — Results of Operations
- [13] Item 7, MD&A — Results of Operations
- [14] Item 7, MD&A — Results of Operations
- [15] Item 7, MD&A — Results of Operations
- [16] Item 7, MD&A — Results of Operations
- [17] Item 7, MD&A — Results of Operations
- [18] Item 7, MD&A — Results of Operations
- [19] Item 7, MD&A — Results of Operations
- [20] Item 7, MD&A — Results of Operations
- [21] Item 7, MD&A — Results of Operations
- [22] Item 7, MD&A — Results of Operations
- [23] Item 7, MD&A — Results of Operations
- [24] Item 7, MD&A — Results of Operations
- [25] Item 7, MD&A — Results of Operations
- [26] Item 7, MD&A — Results of Operations
- [27] Item 7, MD&A — Results of Operations
- [28] Item 7, MD&A — Results of Operations
- [29] Item 7, MD&A — Results of Operations
- [30] Item 7, MD&A — Results of Operations
- [31] Item 7, MD&A — Results of Operations
- [32] Item 7, MD&A — Results of Operations
- [33] Item 7, MD&A — Results of Operations
- [34] Item 7, MD&A — Results of Operations
- [35] Item 7, MD&A — Results of Operations
- [36] Item 7, MD&A — Results of Operations
- [37] Item 7, MD&A — Results of Operations
- [38] Item 7, MD&A — Results of Operations
- [39] Item 7, MD&A — Results of Operations
- [40] Item 7, MD&A — Results of Operations
- [41] Item 7, MD&A — Results of Operations
- [42] Item 7, MD&A — Results of Operations
- [43] Item 7, MD&A — Results of Operations
- [44] Item 7, MD&A — Results of Operations
- [45] Item 7, MD&A — Results of Operations
- [46] Item 7, MD&A — Results of Operations
- [47] Item 7, MD&A — Results of Operations
- [48] Item 7, MD&A — Results of Operations
- [49] Item 7, MD&A — Results of Operations
- [50] Item 7, MD&A — Results of Operations
- [51] Item 7, MD&A — Results of Operations
- [52] Item 7, MD&A — Results of Operations
- [53] Item 7, MD&A — Results of Operations
- [54] Item 7, MD&A — Results of Operations
- [55] Item 7, MD&A — Results of Operations
- [56] Item 7, MD&A — Results of Operations
- [57] Item 7, MD&A — Results of Operations
- [58] Item 7, MD&A — Results of Operations
- [59] Item 7, MD&A — Results of Operations
- [60] Item 7, MD&A — Results of Operations
- [61] Item 7, MD&A — Results of Operations
- [62] Item 7, MD&A — Results of Operations
- [63] Item 7, MD&A — Results of Operations
- [64] Item 7, MD&A — Results of Operations
- [65] Item 7, MD&A — Results of Operations
- [66] Item 7, MD&A — Results of Operations
- [67] Item 7, MD&A — Results of Operations
- [68] Item 7, MD&A — Results of Operations
- [69] Item 7, MD&A — Results of Operations
- [70] Item 7, MD&A — Results of Operations
- [71] Item 7, MD&A — Results of Operations
- [72] Item 7, MD&A — Results of Operations
- [73] Item 7, MD&A — Results of Operations
- [74] Item 7, MD&A — Results of Operations
- [75] Item 7, MD&A — Results of Operations
- [76] Item 7, MD&A — Results of Operations
- [77] Item 7, MD&A — Results of Operations
- [78] Item 7, MD&A — Results of Operations
- [79] Item 7, MD&A — Results of Operations
- [80] Item 7, MD&A — Results of Operations
- [81] Item 7, MD&A — Results of Operations
- [82] Item 7, MD&A — Results of Operations
- [83] Item 7, MD&A — Results of Operations
- [84] Item 7, MD&A — Results of Operations
- [85] Item 7, MD&A — Results of Operations
- [86] Item 7, MD&A — Results of Operations
- [87] Item 7, MD&A — Results of Operations
- [88] Item 7, MD&A — Results of Operations
- [89] Item 7, MD&A — Results of Operations
- [90] Item 7, MD&A — Results of Operations
- [91] Item 7, MD&A — Results of Operations
- [92] Item 7, MD&A — Results of Operations
- [93] Item 7, MD&A — Results of Operations
- [94] Item 7, MD&A — Results of Operations
- [95] Item 7, MD&A — Results of Operations
- [96] Item 7, MD&A — Results of Operations
- [97] Item 7, MD&A — Results of Operations
- [98] Item 7, MD&A — Results of Operations
- [99] Item 7, MD&A — Results of Operations
- [100] Item 7, MD&A — Results of Operations
- [101] Item 7, MD&A — Results of Operations
- [102] Item 7, MD&A — Results of Operations
- [103] Item 7, MD&A — Results of Operations
- [104] Item 7, MD&A — Results of Operations
- [105] Item 7, MD&A — Results of Operations
- [106] Item 7, MD&A — Results of Operations
- [107] Item 7, MD&A — Results of Operations
- [108] Item 7, MD&A — Results of Operations
- [109] Item 7, MD&A — Results of Operations
- [110] Item 7, MD&A — Results of Operations
- [111] Item 7, MD&A — Results of Operations
- [112] Item 7, MD&A — Results of Operations
- [113] Item 7, MD&A — Results of Operations
- [114] Item 7, MD&A — Results of Operations
- [115] Item 7, MD&A — Results of Operations
- [116] Item 7, MD&A — Results of Operations
- [117] Item 7, MD&A — Results of Operations
- [118] Item 7, MD&A — Results of Operations
- [119] Item 7, MD&A — Results of Operations
- [120] Item 7, MD&A — Results of Operations
- [121] Item 7, MD&A — Results of Operations
- [122] Item 7, MD&A — Results of Operations
- [123] Item 7, MD&A — Results of Operations
- [124] Item 7, MD&A — Results of Operations
- [125] Item 7, MD&A — Results of Operations
- [126] Item 7, MD&A — Results of Operations
- [127] Item 7, MD&A — Results of Operations
- [128] Item 7, MD&A — Results of Operations
- [129] Item 7, MD&A — Results of Operations
- [130] Item 7, MD&A — Results of Operations
- [131] Item 7, MD&A — Results of Operations
- [132] Item 7, MD&A — Results of Operations
- [133] Item 7, MD&A — Results of Operations
- [134] Item 7, MD&A — Results of Operations
- [135] Item 7, MD&A — Results of Operations
- [136] Item 7, MD&A — Results of Operations
- [137] Item 7, MD&A — Results of Operations
- [138] Item 7, MD&A — Results of Operations
- [139] Item 7, MD&A — Results of Operations
- [140] Item 7, MD&A — Results of Operations
- [141] Item 7, MD&A — Results of Operations
- [142] Item 7, MD&A — Results of Operations
- [143] Item 7, MD&A — Results of Operations
- [144] Item 7, MD&A — Results of Operations
- [145] Item 7, MD&A — Results of Operations
- [146] Item 7, MD&A — Results of Operations
- [147] Item 7, MD&A — Results of Operations
- [148] Item 7, MD&A — Results of Operations
- [149] Item 7, MD&A — Results of Operations
- [150] Item 7, MD&A — Results of Operations
- [151] Item 7, MD&A — Results of Operations
- [152] Item 7, MD&A — Results of Operations
- [153] Item 7, MD&A — Results of Operations
- [154] Item 7, MD&A — Results of Operations
- [155] Item 7, MD&A — Results of Operations
- [156] Item 7, MD&A — Results of Operations
- [157] Item 7, MD&A — Results of Operations
- [158] Item 7, MD&A — Results of Operations
- [159] Item 7, MD&A — Results of Operations
- [160] Item 7, MD&A — Results of Operations
- [161] Item 7, MD&A — Results of Operations
- [162] Item 7, MD&A — Results of Operations
- [163] Item 7, MD&A — Results of Operations
- [164] Item 7, MD&A — Results of Operations
- [165] Item 7, MD&A — Results of Operations
- [166] Item 7, MD&A — Results of Operations
- [167] Item 7, MD&A — Results of Operations
- [168] Item 7, MD&A — Results of Operations
- [169] Item 7, MD&A — Results of Operations
- [170] Item 7, MD&A — Results of Operations
- [171] Item 7, MD&A — Results of Operations
- [172] Item 7, MD&A — Results of Operations
- [173] Item 7, MD&A — Results of Operations
- [174] Item 7, MD&A — Results of Operations
- [175] Item 7, MD&A — Results of Operations
- [176] Item 7, MD&A — Results of Operations
- [177] Item 7, MD&A — Results of Operations
- [178] Item 7, MD&A — Results of Operations
- [179] Item 7, MD&A — Results of Operations
- [180] Item 7, MD&A — Results of Operations
- [181] Item 7, MD&A — Results of Operations
- [182] Item 7, MD&A — Results of Operations
- [183] Item 7, MD&A — Results of Operations
- [184] Item 7, MD&A — Results of Operations
- [185] Item 7, MD&A — Results of Operations
- [186] Item 7, MD&A — Results of Operations
- [187] Item 7, MD&A — Results of Operations
- [188] Item 7, MD&A — Results of Operations
- [189] Item 7, MD&A — Results of Operations
- [190] Item 7, MD&A — Results of Operations
- [191] Item 7, MD&A — Results of Operations
- [192] Item 7, MD&A — Results of Operations
- [193] Item 7, MD&A — Results of Operations
- [194] Item 7, MD&A — Results of Operations
- [195] Item 7, MD&A — Results of Operations
- [196] Item 7, MD&A — Results of Operations
- [197] Item 7, MD&A — Results of Operations
- [198] Item 7, MD&A — Results of Operations
- [199] Item 7, MD&A — Results of Operations
- [200] Item 7, MD&A — Results of Operations
- [201] Item 7, MD&A — Results of Operations
- [202] Item 7, MD&A — Results of Operations
- [203] Item 7, MD&A — Results of Operations
- [204] Item 7, MD&A — Results of Operations
- [205] Item 7, MD&A — Results of Operations
- [206] Item 7, MD&A — Results of Operations
- [207] Item 7, MD&A — Results of Operations
- [208] Item 7, MD&A — Results of Operations
- [209] Item 7, MD&A — Results of Operations
- [210] Item 7, MD&A — Results of Operations
- [211] Item 7, MD&A — Results of Operations
- [212] Item 7, MD&A — Results of Operations
- [213] Item 7, MD&A — Results of Operations
- [214] Item 7, MD&A — Results of Operations
- [215] Item 7, MD&A — Results of Operations
- [216] Item 7, MD&A — Results of Operations
- [217] Item 7, MD&A — Results of Operations
- [218] Item 7, MD&A — Results of Operations
- [219] Item 7, MD&A — Results of Operations
- [220] Item 7, MD&A — Results of Operations
- [221] Item 7, MD&A — Results of Operations
- [222] Item 7, MD&A — Results of Operations
- [223] Item 7, MD&A — Results of Operations
- [224] Item 7, MD&A — Results of Operations
- [225] Item 7, MD&A — Results of Operations
- [226] Item 7, MD&A — Results of Operations
- [227] Item 7, MD&A — Results of Operations
- [228] Item 7, MD&A — Results of Operations
- [229] Item 7, MD&A — Results of Operations
- [230] Item 7, MD&A — Results of Operations
- [231] Item 7, MD&A — Results of Operations
- [232] Item 7, MD&A — Results of Operations
- [233] Item 7, MD&A — Results of Operations
- [234] Item 7, MD&A — Results of Operations
- [235] Item 7, MD&A — Results of Operations
- [236] Item 7, MD&A — Results of Operations
- [237] Item 7, MD&A — Results of Operations
- [238] Item 7, MD&A — Results of Operations
- [239] Item 7, MD&A — Results of Operations
- [240] Item 7, MD&A — Results of Operations
- [241] Item 7, MD&A — Results of Operations
- [242] Item 7, MD&A — Results of Operations
- [243] Item 7, MD&A — Results of Operations
- [244] Item 7, MD&A — Results of Operations
- [245] Item 7, MD&A — Results of Operations
- [246] Item 7, MD&A — Results of Operations
- [247] Item 7, MD&A — Results of Operations
- [248] Item 7, MD&A — Results of Operations
- [249] Item 7, MD&A — Results of Operations
- [250] Item 7, MD&A — Results of Operations
- [251] Item 7, MD&A — Results of Operations
- [252] Item 7, MD&A — Results of Operations
- [253] Item 7, MD&A — Results of Operations
- [254] Item 7, MD&A — Results of Operations
- [255] Item 7, MD&A — Results of Operations
- [256] Item 7, MD&A — Results of Operations
- [257] Item 7, MD&A — Results of Operations
- [258] Item 7, MD&A — Results of Operations
- [259] Item 7, MD&A — Results of Operations
- [260] Item 7, MD&A — Results of Operations
- [261] Item 7, MD&A — Results of Operations
- [262] Item 7, MD&A — Results of Operations
- [263] Item 7, MD&A — Results of Operations
- [264] Item 7, MD&A — Results of Operations
- [265] Item 7, MD&A — Results of Operations
- [266] Item 7, MD&A — Results of Operations
- [267] Item 7, MD&A — Results of Operations
- [268] Item 7, MD&A — Results of Operations
- [269] Item 7, MD&A — Results of Operations
- [270] Item 7, MD&A — Results of Operations
- [271] Item 7, MD&A — Results of Operations
- [272] Item 7, MD&A — Results of Operations
- [273] Item 7, MD&A — Results of Operations
- [274] Item 7, MD&A — Results of Operations
- [275] Item 7, MD&A — Results of Operations
- [276] Item 7, MD&A — Results of Operations
- [277] Item 7, MD&A — Results of Operations
- [278] Item 7, MD&A — Results of Operations
- [279] Item 7, MD&A — Results of Operations
- [280] Item 7, MD&A — Results of Operations
- [281] Item 7, MD&A — Results of Operations
- [282] Item 7, MD&A — Results of Operations
- [283] Item 7, MD&A — Results of Operations
- [284] Item 7, MD&A — Results of Operations
- [285] Item 7, MD&A — Results of Operations
- [286] Item 7, MD&A — Results of Operations
- [287] Item 7, MD&A — Results of Operations
- [288] Item 7, MD&A — Results of Operations
- [289] Item 7, MD&A — Results of Operations
- [290] Item 7, MD&A — Results of Operations
- [291] Item 7, MD&A — Results of Operations
- [292] Item 7, MD&A — Results of Operations
- [293] Item 7, MD&A — Results of Operations
- [294] Item 7, MD&A — Results of Operations
- [295] Item 7, MD&A — Results of Operations
- [296] Item 7, MD&A — Results of Operations
- [297] Item 7, MD&A — Results of Operations
- [298] Item 7, MD&A — Results of Operations
- [299] Item 7, MD&A — Results of Operations
- [300] Item 7, MD&A — Results of Operations
- [301] Item 7, MD&A — Results of Operations
- [302] Item 7, MD&A — Results of Operations
- [303] Item 7, MD&A — Results of Operations
- [304] Item 7, MD&A — Results of Operations
- [305] Item 7, MD&A — Results of Operations
- [306] Item 7, MD&A — Results of Operations
- [307] Item 7, MD&A — Results of Operations
- [308] Item 7, MD&A — Results of Operations
- [309] Item 7, MD&A — Results of Operations
- [310] Item 7, MD&A — Results of Operations
- [311] Item 7, MD&A — Results of Operations
- [312] Item 7, MD&A — Results of Operations
- [313] Item 7, MD&A — Results of Operations
- [314] Item 7, MD&A — Results of Operations
- [315] Item 7, MD&A — Results of Operations
- [316] Item 7, MD&A — Results of Operations
- [317] Item 7, MD&A — Results of Operations
- [318] Item 7, MD&A — Results of Operations
- [319] Item 7, MD&A — Results of Operations
- [320] Item 7, MD&A — Results of Operations
- [321] Item 7, MD&A — Results of Operations
- [322] Item 7, MD&A — Results of Operations
- [323] Item 7, MD&A — Results of Operations
- [324] Item 7, MD&A — Results of Operations
- [325] Item 7, MD&A — Results of Operations
- [326] Item 7, MD&A — Results of Operations
- [327] Item 7, MD&A — Results of Operations
- [328] Item 7, MD&A — Results of Operations
- [329] Item 7, MD&A — Results of Operations
- [330] Item 7, MD&A — Results of Operations
- [331] Item 7, MD&A — Results of Operations
- [332] Item 7, MD&A — Results of Operations
- [333] Item 7, MD&A — Results of Operations
- [334] Item 7, MD&A — Results of Operations
- [335] Item 7, MD&A — Results of Operations
- [336] Item 7, MD&A — Results of Operations
- [337] Item 7, MD&A — Results of Operations
- [338] Item 7, MD&A — Results of Operations
- [339] Item 7, MD&A — Results of Operations
- [340] Item 7, MD&A — Results of Operations
- [341] Item 7, MD&A — Results of Operations
- [342] Item 7, MD&A — Results of Operations
- [343] Item 7, MD&A — Results of Operations
- [344] Item 7, MD&A — Results of Operations
- [345] Item 7, MD&A — Results of Operations
- [346] Item 7, MD&A — Results of Operations
- [347] Item 7, MD&A — Results of Operations
- [348] Item 7, MD&A — Results of Operations
- [349] Item 7, MD&A — Results of Operations
- [350] Item 7, MD&A — Results of Operations
- [351] Item 7, MD&A — Results of Operations
- [352] Item 7, MD&A — Results of Operations
- [353] Item 7, MD&A — Results of Operations
- [354] Item 7, MD&A — Results of Operations
- [355] Item 7, MD&A — Results of Operations
- [356] Item 7, MD&A — Results of Operations
- [357] Item 7, MD&A — Results of Operations
- [358] Item 7, MD&A — Results of Operations
- [359] Item 7, MD&A — Results of Operations
- [360] Item 7, MD&A — Results of Operations
- [361] Item 7, MD&A — Results of Operations
- [362] Item 7, MD&A — Results of Operations
- [363] Item 7, MD&A — Results of Operations
- [364] Item 7, MD&A — Results of Operations
- [365] Item 7, MD&A — Results of Operations
- [366] Item 7, MD&A — Results of Operations
- [367] Item 7, MD&A — Results of Operations
- [368] Item 7, MD&A — Results of Operations
- [369] Item 7, MD&A — Results of Operations
- [370] Item 7, MD&A — Results of Operations
- [371] Item 7, MD&A — Results of Operations
- [372] Item 7, MD&A — Results of Operations
- [373] Item 7, MD&A — Results of Operations
- [374] Item 7, MD&A — Results of Operations
- [375] Item 7, MD&A — Results of Operations
- [376] Item 7, MD&A — Results of Operations
- [377] Item 7, MD&A — Results of Operations
- [378] Item 7, MD&A — Results of Operations
- [379] Item 7, MD&A — Results of Operations
- [380] Item 7, MD&A — Results of Operations
- [381] Item 7, MD&A — Results of Operations
- [382] Item 7, MD&A — Results of Operations
- [383] Item 7, MD&A — Results of Operations
- [384] Item 7, MD&A — Results of Operations
- [385] Item 7, MD&A — Results of Operations
- [386] Item 7, MD&A — Results of Operations
- [387] Item 7, MD&A — Results of Operations
- [388] Item 7, MD&A — Results of Operations
- [389] Item 7, MD&A — Results of Operations
- [390] Item 7, MD&A — Results of Operations
- [391] Item 7, MD&A — Results of Operations
- [392] Item 7, MD&A — Results of Operations
- [393] Item 7, MD&A — Results of Operations
- [394] Item 7, MD&A — Results of Operations
- [395] Item 7, MD&A — Results of Operations
- [396] Item 7, MD&A — Results of Operations
- [397] Item 7, MD&A — Results of Operations
- [398] Item 7, MD&A — Results of Operations
- [399] Item 7, MD&A — Results of Operations
- [400] Item 7, MD&A — Results of Operations
- [401] Item 7, MD&A — Results of Operations
- [402] Item 7, MD&A — Results of Operations
- [403] Item 7, MD&A — Results of Operations
- [404] Item 7, MD&A — Results of Operations
- [405] Item 7, MD&A — Results of Operations
- [406] Item 7, MD&A — Results of Operations
- [407] Item 7, MD&A — Results of Operations
- [408] Item 7, MD&A — Results of Operations
- [409] Item 7, MD&A — Results of Operations
- [410] Item 7, MD&A — Results of Operations
- [411] Item 7, MD&A — Results of Operations
- [412] Item 7, MD&A — Results of Operations
- [413] Item 7, MD&A — Results of Operations
- [414] Item 7, MD&A — Results of Operations
- [415] Item 7, MD&A — Results of Operations
- [416] Item 7, MD&A — Results of Operations
- [417] Item 7, MD&A — Results of Operations
- [418] Item 7, MD&A — Results of Operations
- [419] Item 7, MD&A — Results of Operations
- [420] Item 7, MD&A — Results of Operations
- [421] Item 7, MD&A — Results of Operations
- [422] Item 7, MD&A — Results of Operations
- [423] Item 7, MD&A — Results of Operations
- [424] Item 7, MD&A — Results of Operations
- [425] Item 7, MD&A — Results of Operations
- [426] Item 7, MD&A — Results of Operations
- [427] Item 7, MD&A — Results of Operations
- [428] Item 7, MD&A — Results of Operations
- [429] Item 7, MD&A — Results of Operations
- [430] Item 7, MD&A — Results of Operations
- [431] Item 7, MD&A — Results of Operations
- [432] Item 7, MD&A — Results of Operations
- [433] Item 7, MD&A — Results of Operations
- [434] Item 7, MD&A — Results of Operations
- [435] Item 7, MD&A — Results of Operations
- [436] Item 7, MD&A — Results of Operations
- [437] Item 7, MD&A — Results of Operations
- [438] Item 7, MD&A — Results of Operations
- [439] Item 7, MD&A — Results of Operations
- [440] Item 7, MD&A — Results of Operations
- [441] Item 7, MD&A — Results of Operations
- [442] Item 7, MD&A — Results of Operations
- [443] Item 7, MD&A — Results of Operations
- [444] Item 7, MD&A — Results of Operations
- [445] Item 7, MD&A — Results of Operations
- [446] Item 7, MD&A — Results of Operations
- [447] Item 7, MD&A — Results of Operations
- [448] Item 7, MD&A — Results of Operations
- [449] Item 7, MD&A — Results of Operations
- [450] Item 7, MD&A — Results of Operations
- [451] Item 7, MD&A — Results of Operations
- [452] Item 7, MD&A — Results of Operations
- [453] Item 7, MD&A — Results of Operations
- [454] Item 7, MD&A — Results of Operations
- [455] Item 7, MD&A — Results of Operations
- [456] Item 7, MD&A — Results of Operations
- [457] Item 7, MD&A — Results of Operations
- [458] Item 7, MD&A — Results of Operations
- [459] Item 7, MD&A — Results of Operations
- [460] Item 7, MD&A — Results of Operations
- [461] Item 7, MD&A — Results of Operations
- [462] Item 7, MD&A — Results of Operations
- [463] Item 7, MD&A — Results of Operations
- [464] Item 7, MD&A — Results of Operations
- [465] Item 7, MD&A — Results of Operations
- [466] Item 7, MD&A — Results of Operations
- [467] Item 7, MD&A — Results of Operations
- [468] Item 7, MD&A — Results of Operations
- [469] Item 7, MD&A — Results of Operations
- [470] Item 7, MD&A — Results of Operations
- [471] Item 7, MD&A — Results of Operations
- [472] Item 7, MD&A — Results of Operations
- [473] Item 7, MD&A — Results of Operations
- [474] Item 7, MD&A — Results of Operations
- [475] Item 7, MD&A — Results of Operations
- [476] Item 7, MD&A — Results of Operations
- [477] Item 7, MD&A — Results of Operations
- [478] Item 7, MD&A — Results of Operations
- [479] Item 7, MD&A — Results of Operations
- [480] Item 7, MD&A — Results of Operations
- [481] Item 7, MD&A — Results of Operations
- [482] Item 7, MD&A — Results of Operations
- [483] Item 7, MD&A — Results of Operations
- [484] Item 7, MD&A — Results of Operations
- [485] Item 7, MD&A — Results of Operations
- [486] Item 7, MD&A — Results of Operations
- [487] Item 7, MD&A — Results of Operations
- [488] Item 7, MD&A — Results of Operations
- [489] Item 7, MD&A — Results of Operations
- [490] Item 7, MD&A — Results of Operations
- [491] Item 7, MD&A — Results of Operations
- [492] Item 7, MD&A — Results of Operations
- [493] Item 7, MD&A — Results of Operations
- [494] Item 7, MD&A — Results of Operations
- [495] Item 7, MD&A — Results of Operations
- [496] Item 7, MD&A — Results of Operations
- [497] Item 7, MD&A — Results of Operations
- [498] Item 7, MD&A — Results of Operations
- [499] Item 7, MD&A — Results of Operations
- [500] Item 7, MD&A — Results of Operations
- [501] Item 7, MD&A — Results of Operations
- [502] Item 7, MD&A — Results of Operations
- [503] Item 7, MD&A — Results of Operations
- [504] Item 7, MD&A — Results of Operations
- [505] Item 7, MD&A — Results of Operations
- [506] Item 7, MD&A — Results of Operations
- [507] Item 7, MD&A — Results of Operations
- [508] Item 7, MD&A — Results of Operations
- [509] Item 7, MD&A — Results of Operations
- [510] Item 7, MD&A — Results of Operations
- [511] Item 7, MD&A — Results of Operations
- [512] Item 7, MD&A — Results of Operations
- [513] Item 7, MD&A — Results of Operations
- [514] Item 7, MD&A — Results of Operations
- [515] Item 7, MD&A — Results of Operations
- [516] Item 7, MD&A — Results of Operations
- [517] Item 7, MD&A — Results of Operations
- [518] Item 7, MD&A — Results of Operations
- [519] Item 7, MD&A — Results of Operations
- [520] Item 7, MD&A — Results of Operations
- [521] Item 7, MD&A — Results of Operations
- [522] Item 7, MD&A — Results of Operations
- [523] Item 7, MD&A — Results of Operations
- [524] Item 7, MD&A — Results of Operations
- [525] Item 7, MD&A — Results of Operations
- [526] Item 7, MD&A — Results of Operations
- [527] Item 7, MD&A — Results of Operations
- [528] Item 7, MD&A — Results of Operations
- [529] Item 7, MD&A — Results of Operations
- [530] Item 7, MD&A — Results of Operations
- [531] Item 7, MD&A — Results of Operations
- [532] Item 7, MD&A — Results of Operations
- [533] Item 7, MD&A — Results of Operations
- [534] Item 7, MD&A — Results of Operations
- [535] Item 7, MD&A — Results of Operations
- [536] Item 7, MD&A — Results of Operations
- [537] Item 7, MD&A — Results of Operations
- [538] Item 7, MD&A — Results of Operations
- [539] Item 7, MD&A — Results of Operations
- [540] Item 7, MD&A — Results of Operations
- [541] Item 7, MD&A — Results of Operations
- [542] Item 7, MD&A — Results of Operations
- [543] Item 7, MD&A — Results of Operations
- [544] Item 7, MD&A — Results of Operations
- [545] Item 7, MD&A — Results of Operations
- [546] Item 7, MD&A — Results of Operations
- [547] Item 7, MD&A — Results of Operations
- [548] Item 7, MD&A — Results of Operations
- [549] Item 7, MD&A — Results of Operations
- [550] Item 7, MD&A — Results of Operations
- [551] Item 7, MD&A — Results of Operations
- [552] Item 7, MD&A — Results of Operations
- [553] Item 7, MD&A — Results of Operations
- [554] Item 7, MD&A — Results of Operations
- [555] Item 7, MD&A — Results of Operations
- [556] Item 7, MD&A — Results of Operations
- [557] Item 7, MD&A — Results of Operations
- [558] Item 7, MD&A — Results of Operations
- [559] Item 7, MD&A — Results of Operations
- [560] Item 7, MD&A — Results of Operations
- [561] Item 7, MD&A — Results of Operations
- [562] Item 7, MD&A — Results of Operations
- [563] Item 7, MD&A — Results of Operations
- [564] Item 7, MD&A — Results of Operations
- [565] Item 7, MD&A — Results of Operations
- [566] Item 7, MD&A — Results of Operations
- [567] Item 7, MD&A — Results of Operations
- [568] Item 7, MD&A — Results of Operations
- [569] Item 7, MD&A — Results of Operations
- [570] Item 7, MD&A — Results of Operations
- [571] Item 7, MD&A — Results of Operations
- [572] Item 7, MD&A — Results of Operations
- [573] Item 7, MD&A — Results of Operations
- [574] Item 7, MD&A — Results of Operations
- [575] Item 7, MD&A — Results of Operations
- [576] Item 7, MD&A — Results of Operations
- [577] Item 7, MD&A — Results of Operations
- [578] Item 7, MD&A — Results of Operations
- [579] Item 7, MD&A — Results of Operations
- [580] Item 7, MD&A — Results of Operations
- [581] Item 7, MD&A — Results of Operations
- [582] Item 7, MD&A — Results of Operations
- [583] Item 7, MD&A — Results of Operations
- [584] Item 7, MD&A — Results of Operations
- [585] Item 7, MD&A — Results of Operations
- [586] Item 7, MD&A — Results of Operations
- [587] Item 7, MD&A — Results of Operations
- [588] Item 7, MD&A — Results of Operations
- [589] Item 7, MD&A — Results of Operations
- [590] Item 7, MD&A — Results of Operations
- [591] Item 7, MD&A — Results of Operations
- [592] Item 7, MD&A — Results of Operations
- [593] Item 7, MD&A — Results of Operations
- [594] Item 7, MD&A — Results of Operations
- [595] Item 7, MD&A — Results of Operations
- [596] Item 7, MD&A — Results of Operations
- [597] Item 7, MD&A — Results of Operations
- [598] Item 7, MD&A — Results of Operations
- [599] Item 7, MD&A — Results of Operations
- [600] Item 7, MD&A — Results of Operations
- [601] Item 7, MD&A — Results of Operations
- [602] Item 7, MD&A — Results of Operations
- [603] Item 7, MD&A — Results of Operations
- [604] Item 7, MD&A — Results of Operations
- [605] Item 7, MD&A — Results of Operations
- [606] Item 7, MD&A — Results of Operations
- [607] Item 7, MD&A — Results of Operations
- [608] Item 7, MD&A — Results of Operations
- [609] Item 7, MD&A — Results of Operations
- [610] Item 7, MD&A — Results of Operations
- [611] Item 7, MD&A — Results of Operations
- [612] Item 7, MD&A — Results of Operations
- [613] Item 7, MD&A — Results of Operations
- [614] Item 7, MD&A — Results of Operations
- [615] Item 7, MD&A — Results of Operations
- [616] Item 7, MD&A — Results of Operations
- [617] Item 7, MD&A — Results of Operations
- [618] Item 7, MD&A — Results of Operations
- [619] Item 7, MD&A — Results of Operations
- [620] Item 7, MD&A — Results of Operations
- [621] Item 7, MD&A — Results of Operations
- [622] Item 7, MD&A — Results of Operations
- [623] Item 7, MD&A — Results of Operations
- [624] Item 7, MD&A — Results of Operations
- [625] Item 7, MD&A — Results of Operations
- [626] Item 7, MD&A — Results of Operations
- [627] Item 7, MD&A — Results of Operations
- [628] Item 7, MD&A — Results of Operations
- [629] Item 7, MD&A — Results of Operations
- [630] Item 7, MD&A — Results of Operations
- [631] Item 7, MD&A — Results of Operations
- [632] Item 7, MD&A — Results of Operations
- [633] Item 7, MD&A — Results of Operations
- [634] Item 7, MD&A — Results of Operations
- [635] Item 7, MD&A — Results of Operations
- [636] Item 7, MD&A — Results of Operations
- [637] Item 7, MD&A — Results of Operations
- [638] Item 7, MD&A — Results of Operations
- [639] Item 7, MD&A — Results of Operations
- [640] Item 7, MD&A — Results of Operations
- [641] Item 7, MD&A — Results of Operations
- [642] Item 7, MD&A — Results of Operations
- [643] Item 7, MD&A — Results of Operations
- [644] Item 7, MD&A — Results of Operations
- [645] Item 7, MD&A — Results of Operations
- [646] Item 7, MD&A — Results of Operations
- [647] Item 7, MD&A — Results of Operations
- [648] Item 7, MD&A — Results of Operations
- [649] Item 7, MD&A — Results of Operations
- [650] Item 7, MD&A — Results of Operations
- [651] Item 7, MD&A — Results of Operations
- [652] Item 7, MD&A — Results of Operations
- [653] Item 7, MD&A — Results of Operations
- [654] Item 7, MD&A — Results of Operations
- [655] Item 7, MD&A — Results of Operations
- [656] Item 7, MD&A — Results of Operations
- [657] Item 7, MD&A — Results of Operations
- [658] Item 7, MD&A — Results of Operations
- [659] Item 7, MD&A — Results of Operations
- [660] Item 7, MD&A — Results of Operations
- [661] Item 7, MD&A — Results of Operations
- [662] Item 7, MD&A — Results of Operations
- [663] Item 7, MD&A — Results of Operations
- [664] Item 7, MD&A — Results of Operations
- [665] Item 7, MD&A — Results of Operations
- [666] Item 7, MD&A — Results of Operations
- [667] Item 7, MD&A — Results of Operations
- [668] Item 7, MD&A — Results of Operations
- [669] Item 7, MD&A — Results of Operations
- [670] Item 7, MD&A — Results of Operations
- [671] Item 7, MD&A — Results of Operations
- [672] Item 7, MD&A — Results of Operations
- [673] Item 7, MD&A — Results of Operations
- [674] Item 7, MD&A — Results of Operations
- [675] Item 7, MD&A — Results of Operations
- [676] Item 7, MD&A — Results of Operations
- [677] Item 7, MD&A — Results of Operations
- [678] Item 7, MD&A — Results of Operations
- [679] Item 7, MD&A — Results of Operations
- [680] Item 7, MD&A — Results of Operations
- [681] Item 7, MD&A — Results of Operations
- [682] Item 7, MD&A — Results of Operations
- [683] Item 7, MD&A — Results of Operations
- [684] Item 7, MD&A — Results of Operations
- [685] Item 7, MD&A — Results of Operations
- [686] Item 7, MD&A — Results of Operations
- [687] Item 7, MD&A — Results of Operations
- [688] Item 7, MD&A — Results of Operations
- [689] Item 7, MD&A — Results of Operations
- [690] Item 7, MD&A — Results of Operations
- [691] Item 7, MD&A — Results of Operations
- [692] Item 7, MD&A — Results of Operations
- [693] Item 7, MD&A — Results of Operations
- [694] Item 7, MD&A — Results of Operations
- [695] Item 7, MD&A — Results of Operations
- [696] Item 7, MD&A — Results of Operations
- [697] Item 7, MD&A — Results of Operations
- [698] Item 7, MD&A — Results of Operations
- [699] Item 7, MD&A — Results of Operations
- [700] Item 7, MD&A — Results of Operations
- [701] Item 7, MD&A — Results of Operations
- [702] Item 7, MD&A — Results of Operations
- [703] Item 7, MD&A — Results of Operations
- [704] Item 7, MD&A — Results of Operations
- [705] Item 7, MD&A — Results of Operations
- [706] Item 7, MD&A — Results of Operations
- [707] Item 7, MD&A — Results of Operations
- [708] Item 7, MD&A — Results of Operations
- [709] Item 7, MD&A — Results of Operations
- [710] Item 7, MD&A — Results of Operations
- [711] Item 7, MD&A — Results of Operations
- [712] Item 7, MD&A — Results of Operations
- [713] Item 7, MD&A — Results of Operations
- [714] Item 7, MD&A — Results of Operations
- [715] Item 7, MD&A — Results of Operations
- [716] Item 7, MD&A — Results of Operations
- [717] Item 7, MD&A — Results of Operations
- [718] Item 7, MD&A — Results of Operations
- [719] Item 7, MD&A — Results of Operations
- [720] Item 7, MD&A — Results of Operations
- [721] Item 7, MD&A — Results of Operations
- [722] Item 7, MD&A — Results of Operations
- [723] Item 7, MD&A — Results of Operations
- [724] Item 7, MD&A — Results of Operations
- [725] Item 7, MD&A — Results of Operations
- [726] Item 7, MD&A — Results of Operations
- [727] Item 7, MD&A — Results of Operations
- [728] Item 7, MD&A — Results of Operations
- [729] Item 7, MD&A — Results of Operations
- [730] Item 7, MD&A — Results of Operations
- [731] Item 7, MD&A — Results of Operations
- [732] Item 7, MD&A — Results of Operations
- [733] Item 7, MD&A — Results of Operations
- [734] Item 7, MD&A — Results of Operations
- [735] Item 7, MD&A — Results of Operations
- [736] Item 7, MD&A — Results of Operations
- [737] Item 7, MD&A — Results of Operations
- [738] Item 7, MD&A — Results of Operations
- [739] Item 7, MD&A — Results of Operations
- [740] Item 7, MD&A — Results of Operations
- [741] Item 7, MD&A — Results of Operations
- [742] Item 7, MD&A — Results of Operations
- [743] Item 7, MD&A — Results of Operations
- [744] Item 7, MD&A — Results of Operations
- [745] Item 7, MD&A — Results of Operations
- [746] Item 7, MD&A — Results of Operations
- [747] Item 7, MD&A — Results of Operations
- [748] Item 7, MD&A — Results of Operations
- [749] Item 7, MD&A — Results of Operations
- [750] Item 7, MD&A — Results of Operations
- [751] Item 7, MD&A — Results of Operations
- [752] Item 7, MD&A — Results of Operations
- [753] Item 7, MD&A — Results of Operations
- [754] Item 7, MD&A — Results of Operations
- [755] Item 7, MD&A — Results of Operations
- [756] Item 7, MD&A — Results of Operations
- [757] Item 7, MD&A — Results of Operations
- [758] Item 7, MD&A — Results of Operations
- [759] Item 7, MD&A — Results of Operations
- [760] Item 7, MD&A — Results of Operations
- [761] Item 7, MD&A — Results of Operations
- [762] Item 7, MD&A — Results of Operations
- [763] Item 7, MD&A — Results of Operations
- [764] Item 7, MD&A — Results of Operations
- [765] Item 7, MD&A — Results of Operations
- [766] Item 7, MD&A — Results of Operations
- [767] Item 7, MD&A — Results of Operations
- [768] Item 7, MD&A — Results of Operations
- [769] Item 7, MD&A — Results of Operations
- [770] Item 7, MD&A — Results of Operations
- [771] Item 7, MD&A — Results of Operations
- [772] Item 7, MD&A — Results of Operations
- [773] Item 7, MD&A — Results of Operations
- [774] Item 7, MD&A — Results of Operations
- [775] Item 7, MD&A — Results of Operations
- [776] Item 7, MD&A — Results of Operations
- [777] Item 7, MD&A — Results of Operations
- [778] Item 7, MD&A — Results of Operations
- [779] Item 7, MD&A — Results of Operations
- [780] Item 7, MD&A — Results of Operations
- [781] Item 7, MD&A — Results of Operations
- [782] Item 7, MD&A — Results of Operations
- [783] Item 7, MD&A — Results of Operations
- [784] Item 7, MD&A — Results of Operations
- [785] Item 7, MD&A — Results of Operations
- [786] Item 7, MD&A — Results of Operations
- [787] Item 7, MD&A — Results of Operations
- [788] Item 7, MD&A — Results of Operations
- [789] Item 7, MD&A — Results of Operations
- [790] Item 7, MD&A — Results of Operations
- [791] Item 7, MD&A — Results of Operations
- [792] Item 7, MD&A — Results of Operations
- [793] Item 7, MD&A — Results of Operations
- [794] Item 7, MD&A — Results of Operations
- [795] Item 7, MD&A — Results of Operations
- [796] Item 7, MD&A — Results of Operations
- [797] Item 7, MD&A — Results of Operations
- [798] Item 7, MD&A — Results of Operations
- [799] Item 7, MD&A — Results of Operations
- [800] Item 7, MD&A — Results of Operations
- [801] Item 7, MD&A — Results of Operations
- [802] Item 7, MD&A — Results of Operations
- [803] Item 7, MD&A — Results of Operations
- [804] Item 7, MD&A — Results of Operations
- [805] Item 7, MD&A — Results of Operations
- [806] Item 7, MD&A — Results of Operations
- [807] Item 7, MD&A — Results of Operations
- [808] Item 7, MD&A — Results of Operations
- [809] Item 7, MD&A — Results of Operations
- [810] Item 7, MD&A — Results of Operations
- [811] Item 7, MD&A — Results of Operations
- [812] Item 7, MD&A — Results of Operations
- [813] Item 7, MD&A — Results of Operations
- [814] Item 7, MD&A — Results of Operations
- [815] Item 7, MD&A — Results of Operations
- [816] Item 7, MD&A — Results of Operations
- [817] Item 7, MD&A — Results of Operations
- [818] Item 7, MD&A — Results of Operations
- [819] Item 7, MD&A — Results of Operations
- [820] Item 7, MD&A — Results of Operations
- [821] Item 7, MD&A — Results of Operations
- [822] Item 7, MD&A — Results of Operations
- [823] Item 7, MD&A — Results of Operations
- [824] Item 7, MD&A — Results of Operations
- [825] Item 7, MD&A — Results of Operations
- [826] Item 7, MD&A — Results of Operations
- [827] Item 7, MD&A — Results of Operations
- [828] Item 7, MD&A — Results of Operations
- [829] Item 7, MD&A — Results of Operations
- [830] Item 7, MD&A — Results of Operations
- [831] Item 7, MD&A — Results of Operations
- [832] Item 7, MD&A — Results of Operations
- [833] Item 7, MD&A — Results of Operations
- [834] Item 7, MD&A — Results of Operations
- [835] Item 7, MD&A — Results of Operations
- [836] Item 7, MD&A — Results of Operations
- [837] Item 7, MD&A — Results of Operations
- [838] Item 7, MD&A — Results of Operations
- [839] Item 7, MD&A — Results of Operations
- [840] Item 7, MD&A — Results of Operations
- [841] Item 7, MD&A — Results of Operations
- [842] Item 7, MD&A — Results of Operations
- [843] Item 7, MD&A — Results of Operations
- [844] Item 7, MD&A — Results of Operations
- [845] Item 7, MD&A — Results of Operations
- [846] Item 7, MD&A — Results of Operations
- [847] Item 7, MD&A — Results of Operations
- [848] Item 7, MD&A — Results of Operations
- [849] Item 7, MD&A — Results of Operations
- [850] Item 7, MD&A — Results of Operations
- [851] Item 7, MD&A — Results of Operations
- [852] Item 7, MD&A — Results of Operations
- [853] Item 7, MD&A — Results of Operations
- [854] Item 7, MD&A — Results of Operations
- [855] Item 7, MD&A — Results of Operations
- [856] Item 7, MD&A — Results of Operations
- [857] Item 7, MD&A — Results of Operations
- [858] Item 7, MD&A — Results of Operations
- [859] Item 7, MD&A — Results of Operations
- [860] Item 7, MD&A — Results of Operations
- [861] Item 7, MD&A — Results of Operations
- [862] Item 7, MD&A — Results of Operations
- [863] Item 7, MD&A — Results of Operations
- [864] Item 7, MD&A — Results of Operations
- [865] Item 7, MD&A — Results of Operations
- [866] Item 7, MD&A — Results of Operations
- [867] Item 7, MD&A — Results of Operations
- [868] Item 7, MD&A — Results of Operations
- [869] Item 7, MD&A — Results of Operations
- [870] Item 7, MD&A — Results of Operations
- [871] Item 7, MD&A — Results of Operations
- [872] Item 7, MD&A — Results of Operations
- [873] Item 7, MD&A — Results of Operations
- [874] Item 7, MD&A — Results of Operations
- [875] Item 7, MD&A — Results of Operations
- [876] Item 7, MD&A — Results of Operations
- [877] Item 7, MD&A — Results of Operations
- [878] Item 7, MD&A — Results of Operations
- [879] Item 7, MD&A — Results of Operations
- [880] Item 7, MD&A — Results of Operations
- [881] Item 7, MD&A — Results of Operations
- [882] Item 7, MD&A — Results of Operations
- [883] Item 7, MD&A — Results of Operations
- [884] Item 7, MD&A — Results of Operations
- [885] Item 7, MD&A — Results of Operations
- [886] Item 7, MD&A — Results of Operations
- [887] Item 7, MD&A — Results of Operations
- [888] Item 7, MD&A — Results of Operations
- [889] Item 7, MD&A — Results of Operations
- [890] Item 7, MD&A — Results of Operations
- [891] Item 7, MD&A — Results of Operations
- [892] Item 7, MD&A — Results of Operations
- [893] Item 7, MD&A — Results of Operations
- [894] Item 7, MD&A — Results of Operations
- [895] Item 7, MD&A — Results of Operations
- [896] Item 7, MD&A — Results of Operations
- [897] Item 7, MD&A — Results of Operations
- [898] Item 7, MD&A — Results of Operations
- [899] Item 7, MD&A — Results of Operations
- [900] Item 7, MD&A — Results of Operations
- [901] Item 7, MD&A — Results of Operations
- [902] Item 7, MD&A — Results of Operations
- [903] Item 7, MD&A — Results of Operations
- [904] Item 7, MD&A — Results of Operations
- [905] Item 7, MD&A — Results of Operations
- [906] Item 7, MD&A — Results of Operations
- [907] Item 7, MD&A — Results of Operations
- [908] Item 7, MD&A — Results of Operations
- [909] Item 7, MD&A — Results of Operations
- [910] Item 7, MD&A — Results of Operations
- [911] Item 7, MD&A — Results of Operations
- [912] Item 7, MD&A — Results of Operations
- [913] Item 7, MD&A — Results of Operations
- [914] Item 7, MD&A — Results of Operations
- [915] Item 7, MD&A — Results of Operations
- [916] Item 7, MD&A — Results of Operations
- [917] Item 7, MD&A — Results of Operations
- [918] Item 7, MD&A — Results of Operations
- [919] Item 7, MD&A — Results of Operations
- [920] Item 7, MD&A — Results of Operations
- [921] Item 7, MD&A — Results of Operations
- [922] Item 7, MD&A — Results of Operations
- [923] Item 7, MD&A — Results of Operations
- [924] Item 7, MD&A — Results of Operations
- [925] Item 7, MD&A — Results of Operations
- [926] Item 7, MD&A — Results of Operations
- [927] Item 7, MD&A — Results of Operations
- [928] Item 7, MD&A — Results of Operations
- [929] Item 7, MD&A — Results of Operations
- [930] Item 7, MD&A — Results of Operations
- [931] Item 7, MD&A — Results of Operations
- [932] Item 7, MD&A — Results of Operations
- [933] Item 7, MD&A — Results of Operations
- [934] Item 7, MD&A — Results of Operations
- [935] Item 7, MD&A — Results of Operations
- [936] Item 7, MD&A — Results of Operations
- [937] Item 7, MD&A — Results of Operations
- [938] Item 7, MD&A — Results of Operations
- [939] Item 7, MD&A — Results of Operations
- [940] Item 7, MD&A — Results of Operations
- [941] Item 7, MD&A — Results of Operations
- [942] Item 7, MD&A — Results of Operations
- [943] Item 7, MD&A — Results of Operations
- [944] Item 7, MD&A — Results of Operations
- [945] Item 7, MD&A — Results of Operations
- [946] Item 7, MD&A — Results of Operations
- [947] Item 7, MD&A — Results of Operations
- [948] Item 7, MD&A — Results of Operations
- [949] Item 7, MD&A — Results of Operations
- [950] Item 7, MD&A — Results of Operations
- [951] Item 7, MD&A — Results of Operations
- [952] Item 7, MD&A — Results of Operations
- [953] Item 7, MD&A — Results of Operations
- [954] Item 7, MD&A — Results of Operations
- [955] Item 7, MD&A — Results of Operations
- [956] Item 7, MD&A — Results of Operations
- [957] Item 7, MD&A — Results of Operations
- [958] Item 7, MD&A — Results of Operations
- [959] Item 7, MD&A — Results of Operations
- [960] Item 7, MD&A — Results of Operations
- [961] Item 7, MD&A — Results of Operations
- [962] Item 7, MD&A — Results of Operations
- [963] Item 7, MD&A — Results of Operations
- [964] Item 7, MD&A — Results of Operations
- [965] Item 7, MD&A — Results of Operations
- [966] Item 7, MD&A — Results of Operations
- [967] Item 7, MD&A — Results of Operations
- [968] Item 7, MD&A — Results of Operations
- [969] Item 7, MD&A — Results of Operations
- [970] Item 7, MD&A — Results of Operations
- [971] Item 7, MD&A — Results of Operations
- [972] Item 7, MD&A — Results of Operations
- [973] Item 7, MD&A — Results of Operations
- [974] Item 7, MD&A — Results of Operations
- [975] Item 7, MD&A — Results of Operations
- [976] Item 7, MD&A — Results of Operations
- [977] Item 7, MD&A — Results of Operations
- [978] Item 7, MD&A — Results of Operations
- [979] Item 7, MD&A — Results of Operations
- [980] Item 7, MD&A — Results of Operations
- [981] Item 7, MD&A — Results of Operations
- [982] Item 7, MD&A — Results of Operations
- [983] Item 7, MD&A — Results of Operations
- [984] Item 7, MD&A — Results of Operations
- [985] Item 7, MD&A — Results of Operations
- [986] Item 7, MD&A — Results of Operations
- [987] Item 7, MD&A — Results of Operations
- [988] Item 7, MD&A — Results of Operations
- [989] Item 7, MD&A — Results of Operations
- [990] Item 7, MD&A — Results of Operations
- [991] Item 7, MD&A — Results of Operations
- [992] Item 7, MD&A — Results of Operations
- [993] Item 7, MD&A — Results of Operations
- [994] Item 7, MD&A — Results of Operations
- [995] Item 7, MD&A — Results of Operations
- [996] Item 7, MD&A — Results of Operations
- [997] Item 7, MD&A — Results of Operations
- [998] Item 7, MD&A — Results of Operations
- [999] Item 7, MD&A — Results of Operations
- [1000] Item 7, MD&A — Results of Operations
Analysis on 9/23/2026